Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Peter W. Callas"'
Autor:
Chris E. Holmes, Mary Cushman, Samuel Cory, Peter W. Callas, Saulius Butenas, Steven Ades, Shannon M. Prior, Daniel Douce
Publikováno v:
Blood. 128:4947-4947
Background. Cancer patients often display procoagulant activity and are at a risk for developing venous thromboembolism (VTE). Multiple mechanisms may explain this procoagulant state, such as tumor cell expression of tissue factor (TF), host tissue r
Autor:
Michael J. DeSarno, Mary Cushman, Peter W. Callas, John P. Winters, Damon Houghton, Samuel A Merrill, Allen B Repp, Neil A. Zakai
Publikováno v:
Blood. 122:2931-2931
Introduction Governmental agencies recommend risk assessment of venous thrombosis (VT) for medical inpatients at admission and provision of VT prophylaxis for moderate to high risk patients. While several risk factor models for predicting hospital-ac
Clostridium Difficile As a Risk Factor For Hospital-Acquired Venous Thrombosis In Medical Inpatients
Autor:
Christopher D. Huston, John P. Winters, Peter W. Callas, Neil A. Zakai, Michael J. DeSarno, Damon Houghton, Mary Cushman, Allen B Repp, Samuel A Merrill
Publikováno v:
Blood. 122:1682-1682
Introduction The American College of Chest Physicians and government agencies recommend risk stratification and pharmacologic prophylaxis to prevent venous thromboembolism (VT) in hospitalized individuals. While risk factor assessment is often comple
Autor:
Damon Houghton, Neil A. Zakai, Michael J. DeSarno, Mary Cushman, Samuel A Merrill, Allen B Repp, Peter W. Callas, John P. Winters
Publikováno v:
Blood. 122:2933-2933
Introduction Expert guidelines and regulatory agencies recommend that all medical inpatients be assessed for venous thrombosis (VT) risk and pharmacologic prophylaxis provided to at-risk patients. However, anticoagulant prophylaxis may increase the r
Publikováno v:
Blood. 120:2251-2251
Abstract 2251 Introduction: Upper extremity deep vein thrombosis (UEDVT) is an increasingly recognized complication in medical inpatients, contributing to morbidity and increased cost of hospitalizations. Despite the rising use of central venous cath
Autor:
Suzanne E. Judd, Mary Cushman, Aaron R. Folsom, Monika M. Safford, Leslie A. McClure, Neil A. Zakai, Pamela L. Lutsey, Peter W. Callas
Publikováno v:
Blood. 120:396-396
Abstract 396 Introduction: Venous thrombosis (VTE) is thought to be more common in African-origin (black) than Caucasian-origin (white) Americans, however most prior studies are based on administrative databases, are limited in geographic scope, or h
Publikováno v:
Blood. 118:1239-1239
Abstract 1239 Introduction: While various government agencies mandate monitoring for in-hospital VT and use of VT prevention strategies, the incidence and risk factors for symptomatic venous thrombosis (VT) in medical inpatients has not been establis
Publikováno v:
Blood. 116:3166-3166
Abstract 3166 Background: Chronic venous insufficiency (CVI) represents a spectrum of disease characterized by impaired venous return. Deep venous thrombosis (DVT) when complicated by post thrombotic syndrome (PTS) is a well established etiology for
Publikováno v:
Blood. 116:1087-1087
Abstract 1087 Background: Investigations of treatment options for established PTS are limited. Graduated compression stocking therapy (GCS) is often used in clinical practice despite limited research on effectiveness. We postulated that the venous hy
Autor:
Edwin G. Bovill, Irene D. Bezemer, Sandra J. Hasstedt, Peter W. Callas, Robert P. Hebbel, Frits R. Rosendaal
Publikováno v:
Blood. 112:405-405
Through a combination of genotyping and resequencing we have identified 3 SNPs (rs17564430, rs3802858 and rs6589488) in a venous thrombosis (VT) susceptibility gene encoding Immunoglobulin Superfamily 4 (IGSF4), that interacts with protein C (PC) def